Drugs.com - New Drug Approvals

FDA Approves Blujepa (gepotidacin) for the Treatment of...

May 12, 2025 0

London, UK -- 25 March 2025 -- GSK plc (LSE/NYSE: GSK) today announced that the ...

Theratechnologies Receives FDA Approval for Egrifta WR ...

May 12, 2025 0

MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechn...

FDA Approves Gozellix (kit for the preparation of galli...

May 12, 2025 0

Melbourne Australia | 21 March 2025 -- Telix today announces that the United Sta...

Novartis Receives Third FDA Approval for Oral Fabhalta ...

May 12, 2025 0

Basel, March 20, 2025 – Novartis today announced that oral Fabhalta (iptacopan) ...

FDA Approves Tremfya (guselkumab) for Adult Patients wi...

May 12, 2025 0

HORSHAM, Pa. (March 20, 2025) – Johnson & Johnson (NYSE: JNJ) today announced th...

Alnylam Announces FDA Approval of Amvuttra (vutrisiran)...

May 12, 2025 0

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 20, 2025-- Alnylam Pharmaceuticals, Inc....

FDA Approves Pembrolizumab for HER2 Positive Gastric or...

May 12, 2025 0

On March 19, 2025, the Food and Drug Administration granted traditional approval...

FDA Approves Arbli (losartan potassium) Oral Suspension...

May 12, 2025 0

TAMPA, FL, March 18, 2025 (GLOBE NEWSWIRE) -- Scienture Holdings, Inc. NASDAQ: S...

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) a...

May 12, 2025 0

PRINCETON, N.J.--(BUSINESS WIRE) April 11, 2025 -- Bristol Myers Squibb (NYSE: ...

FDA Approves Jobevne (bevacizumab-nwgd), a Biosimilar t...

May 12, 2025 0

BRIDGEWATER, New Jersey and BENGALURU, Karnataka, India, April 10, 2025 -- Bioco...

Argenx Announces FDA Approval of Vyvgart Hytrulo Prefil...

May 12, 2025 0

April 10, 2025 -- argenx SE (Euronext & Nasdaq: ARGX), a global immunology compa...

U.S. FDA Grants Full Approval of Vitrakvi (larotrectini...

May 12, 2025 0

WHIPPANY, N.J.--(BUSINESS WIRE) April 10, 2025 --Bayer today announced that the ...

FDA Approves an Updated Label for Tryvio (aprocitentan)...

May 12, 2025 0

Allschwil, Switzerland – April 9, 2025 Idorsia Ltd (SIX: IDIA) today announced t...

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) a...

May 12, 2025 0

PRINCETON, N.J.--(BUSINESS WIRE)-- Apr 08, 2025 -- Bristol Myers Squibb (NYSE: ...

FDA Grants Accelerated Approval for Vanrafia (atrasenta...

May 12, 2025 0

Basel, April 3, 2025 – Novartis today announced the US Food and Drug Administrat...

Uplizna (inebilizumab-cdon) is Now the First and Only F...

May 12, 2025 0

THOUSAND OAKS, Calif., April 3, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) announc...

Bavarian Nordic Receives U.S. FDA Approval of Jynneos F...

May 12, 2025 0

COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today anno...

FDA Approves Qfitlia (fitusiran) to Treat Hemophilia A ...

May 12, 2025 0

Paris, March 28, 2025. The US Food and Drug Administration (FDA) has approved Qf...

FDA Approves Imfinzi (durvalumab) for Muscle Invasive ...

May 12, 2025 0

On March 28, 2025, the Food and Drug Administration approved durvalumab (Imfinzi...

FDA Approves Bomyntra (denosumab-bnht), a Biosimilar to...

May 12, 2025 0

LAKE ZURICH, Ill., March 27, 2025 -- Fresenius announced that the Biologics Lice...

FDA Approves Conexxence (denosumab-bnht), a Biosimilar ...

May 12, 2025 0

LAKE ZURICH, Ill., March 27, 2025 -- Fresenius announced that the Biologics Lice...

Exelixis Announces U.S. FDA Approval of Cabometyx (cabo...

May 12, 2025 0

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar. 26, 2025-- Exelixis, Inc. (Nasdaq: EXEL) ...

FDA Approves Vykat XR (diazoxide choline) to Treat Hype...

May 12, 2025 0

REDWOOD CITY, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, In...

Rinvoq (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)

Rinvoq (upadacitinib) Receives U.S. FDA Approval for Gi...

May 12, 2025 0

NORTH CHICAGO, Ill., April 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today an...

1
2
3

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.